According to previous studies6,22,56, the prevalence of BRCA1/2 mutations was 12.7%–19.1% in Chinese familial BC patients, which is distinct from the prevalence of BRCA1/2 mutations in this study. This evidence concerns the gene BRCA1 and breast cancer.